Endothelin-Converting Enzyme-1 Degrades Internalized Somatostatin-14
Open Access
- 14 February 2008
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 149 (5), 2200-2207
- https://doi.org/10.1210/en.2007-1628
Abstract
Agonist-induced internalization of somatostatin receptors (ssts) determines subsequent cellular responsiveness to peptide agonists and influences sst receptor scintigraphy. To investigate sst2A trafficking, rat sst2A tagged with epitope was expressed in human embryonic kidney cells and tracked by antibody labeling. Confocal microscopical analysis revealed that stimulation with sst and octreotide induced internalization of sst2A. Internalized sst2A remained sequestrated within early endosomes, and 60 min after stimulation, internalized sst2A still colocalized with β-arrestin1-enhanced green fluorescence protein (EGFP), endothelin-converting enzyme-1 (ECE-1), and rab5a. Internalized 125I-Tyr11-SST-14 was rapidly hydrolyzed by endosomal endopeptidases, with radioactive metabolites being released from the cell. Internalized 125I-Tyr1-octreotide accumulated as an intact peptide and was released from the cell as an intact peptide ligand. We have identified ECE-1 as one of the endopeptidases responsible for inactivation of internalized SST-14. ECE-1-mediated cleavage of SST-14 was inhibited by the specific ECE-1 inhibitor, SM-19712, and by preventing acidification of endosomes using bafilomycin A1. ECE-1 cleaved SST-14 but not octreotide in an acidic environment. The metallopeptidases angiotensin-1 converting enzyme and ECE-2 did not hydrolyze SST-14 or octreotide. Our results show for the first time that stimulation with SST-14 and octreotide induced sequestration of sst2A into early endosomes and that endocytosed SST-14 is degraded by endopeptidases located in early endosomes. Furthermore, octreotide was not degraded by endosomal peptidases and was released as an intact peptide. This mechanism may explain functional differences between octreotide and SST-14 after sst2A stimulation. Moreover, further investigation of endopeptidase-regulated trafficking of neuropeptides may result in novel concepts of neuropeptide receptor inactivation in cancer diagnosis.Keywords
This publication has 34 references indexed in Scilit:
- Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and β-arrestinsThe Journal of cell biology, 2007
- Neuroimmune interactions in allergic skin diseasesCurrent Opinion in Allergy and Clinical Immunology, 2007
- A functional comparison of recombinant and native somatostatin sst2 receptor variants in epitheliaBritish Journal of Pharmacology, 2007
- Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recyclingProceedings of the National Academy of Sciences, 2007
- Human ACE and bradykinin B 2 receptors form a complex at the plasma membraneThe FASEB Journal, 2006
- Endosomal proteolysis of insulin‐like growth factor‐I at its C‐terminal D‐domain by cathepsin BFEBS Letters, 2005
- Rab5 Association with the Angiotensin II Type 1A Receptor Promotes Rab5 GTP Binding and Vesicular FusionJournal of Biological Chemistry, 2002
- Dynamin and Rab5a-dependent Trafficking and Signaling of the Neurokinin 1 ReceptorPublished by Elsevier ,2001
- Identification and characterization of two isoforms of an endothelin‐converting enzyme‐1FEBS Letters, 1995
- Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)FEBS Letters, 1992